Systematic Analysis Of Cost Effectiveness Analysis (Cea) In Health Services: A Review Of National And International Literature
Main Article Content
Abstract
Limited resources and the high burden of disease in Indonesia have prompted the need for economic evaluation in healthcare services. Cost-effectiveness analysis (CEA) is an important approach to assess health interventions in terms of efficiency and impact on clinical outcomes. This study aims to identify and synthesize findings from various studies related to CEA in healthcare interventions in Indonesia. This study used a systematic review method by searching literature from Google Scholar, PubMed, and Science Direct databases. Selection was carried out through the PRISMA stages starting from identification, screening titles and abstracts, to full-text selection, resulting in 9 articles that met the inclusion criteria. Most studies showed that health interventions such as immunization, tuberculosis treatment, diabetes screening, hypertension treatment, and HIV/AIDS services have high cost-effectiveness. Combination therapies or technology-based approaches such as telemedicine have also proven efficient in managing chronic diseases. The evaluation results using ICER and ACER indicators showed that most interventions were cost-effective compared to standard approaches or no intervention at all. CEA is an important tool in supporting evidence-based decision-making in the healthcare sector. Implementing CEA results can help governments and policymakers determine priority interventions that have a significant impact on service quality and budget efficiency.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Alisjahbana, B., van Crevel, R., Sahiratmadja, E., den Heijer, M., Maya, A., Istriana, E., ... & van der Meer, JWM (2005). Evaluation of the Directly Observed Treatment Short-course (DOTS) strategy for tuberculosis control in West Java, Indonesia. Tropical Medicine & International Health , 10 (7), 765–772. https://doi.org/10.1111/j.1365-3156.2005.01453.x
Asmani, F. (2019). Cost-Effectiveness Analysis of the DPT-HB-Hib Immunization Program in Indonesia. Indonesian Journal of Health Policy , 8 (1), 1–10. https://doi.org/10.22146/jkki.44621
Fajrin, RN, & Siregar, AYM (2020). Cost-effectiveness of the national cervical cancer vaccination program in Indonesia: A modeling study. BMC Public Health , 20 , 1306. https://doi.org/10.1186/s12889-020-09413-w
Gani, A., & Budiharsana, M. (2019). The economic evaluation of national health insurance policy in Indonesia. Health Systems & Reform , 5 (1), 58–67. https://doi.org/10.1080/23288604.2018.1561442
Mahendradhata, Y., Trisnantoro, L., Listyadewi, S., Soewondo, P., Marthias, T., Harimurti, P., & Prawira, J. (2017). The Republic of Indonesia Health System Review. Health Systems in Transition , 7 (1). WHO Regional Office for South-East Asia. https://apps.who.int/iris/handle/10665/254716
Nugraheni, WP, & Mubasyiroh, R. (2018). Cost-effectiveness analysis of diabetes mellitus screening in Indonesia. Indonesian Journal of Health Policy , 2 (2), 95–104.
Pradipta, IS, Siregar, AYM, van Hulst, M., Hak, E., & Postma, MJ (2017). Cost-effectiveness of multidrug-resistant tuberculosis treatment in Indonesia: A model-based evaluation. BMJ Open , 7 (11), e017330. https://doi.org/10.1136/bmjopen-2017-017330
Putri, S., Siregar, AYM, & van Asselt, ADI (2021). Economic evaluation of telemedicine for hypertension management in rural Indonesia: A cost-effectiveness analysis. Telemedicine and e-Health , 27 (10), 1051–1059. https://doi.org/10.1089/tmj.2020.0421
Siregar, AYM, Pitriyan, P., & Wisaksana, R. (2014). Cost-effectiveness of HIV treatment in Indonesia: A modeling study. PLoS ONE , 9 (3), e90275. https://doi.org/10.1371/journal.pone.009027 5